THE SENATE Blue Ribbon Committee has formally endorsed the filing of multiple administrative and criminal charges against two former officials of the Procurement Service of the Department of Budget and Management (PS-DBM) for their role in an alleged anomalous deal entered with Pharmally Pharmaceutical Corporation in 2022.
